CRIS Current Research Information System

CONTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.066
AS - Asia 3.590
EU - Europa 2.496
AF - Africa 239
Continente sconosciuto - Info sul continente non disponibili 197
SA - Sud America 183
OC - Oceania 5
Totale 11.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.992
VN - Vietnam 1.198
SG - Singapore 1.000
CN - Cina 704
GB - Regno Unito 608
IT - Italia 441
SE - Svezia 365
DE - Germania 295
HK - Hong Kong 234
FR - Francia 151
IN - India 137
RU - Federazione Russa 133
BR - Brasile 122
IE - Irlanda 103
NL - Olanda 89
CI - Costa d'Avorio 71
BD - Bangladesh 64
TG - Togo 62
ZA - Sudafrica 60
UA - Ucraina 56
EE - Estonia 51
CA - Canada 44
JP - Giappone 39
CH - Svizzera 33
JO - Giordania 33
BG - Bulgaria 32
PH - Filippine 32
BE - Belgio 29
TH - Thailandia 29
AT - Austria 26
FI - Finlandia 25
NG - Nigeria 24
AR - Argentina 21
PL - Polonia 18
KR - Corea 16
ID - Indonesia 15
TR - Turchia 15
EC - Ecuador 14
IQ - Iraq 14
MX - Messico 13
TW - Taiwan 12
IR - Iran 11
PK - Pakistan 11
CO - Colombia 8
SC - Seychelles 8
ES - Italia 7
VE - Venezuela 6
AU - Australia 5
LT - Lituania 5
MY - Malesia 5
CL - Cile 4
CR - Costa Rica 4
PT - Portogallo 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
MK - Macedonia 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
IL - Israele 2
LV - Lettonia 2
NI - Nicaragua 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GL - Groenlandia 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MQ - Martinica 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
Totale 11.582
Salva come PNG Salva come JPEG
Città #
Singapore 736
Fairfield 537
Southend 536
Ashburn 499
Chandler 381
San Jose 308
Ho Chi Minh City 266
Houston 232
Woodbridge 219
Seattle 213
Hanoi 212
Hong Kong 209
Wilmington 197
Dallas 186
Ann Arbor 179
Santa Clara 162
Dong Ket 154
Cambridge 153
Princeton 118
Beijing 109
Boardman 108
Bologna 108
Dublin 102
Abidjan 71
Los Angeles 71
Nanjing 67
Lomé 62
New York 60
Council Bluffs 54
Westminster 53
Da Nang 52
Lauterbourg 49
Padova 43
Haiphong 41
Milan 40
Amman 33
San Diego 32
São Paulo 32
Tokyo 31
Berlin 30
Jinan 30
Sofia 30
Brussels 29
Bern 28
Florence 28
Saint Petersburg 28
Turin 28
Frankfurt am Main 27
Bremen 26
Buffalo 26
Jacksonville 26
Redondo Beach 24
Abeokuta 23
Guangzhou 22
Tianjin 22
Chicago 21
London 21
Phoenix 21
Shenyang 20
Nanchang 18
Helsinki 17
Hải Dương 17
Munich 17
Redmond 17
Vienna 17
Biên Hòa 16
Changsha 16
Dearborn 16
Medford 15
Bến Tre 14
Quận Ba 14
Rome 14
Falls Church 13
Bangkok 12
Brooklyn 12
Bắc Ninh 12
The Dalles 12
Amsterdam 11
Des Moines 11
Hebei 11
Shanghai 11
Toronto 11
Warsaw 11
Wuhan 11
Thái Nguyên 10
Yubileyny 10
Can Tho 9
Haikou 9
Hangzhou 9
Johannesburg 9
Montreal 9
Orem 9
Atlanta 8
Bình Phước 8
Moscow 8
Stockholm 8
Xi'an 8
Zhengzhou 8
Fuzhou 7
Lanzhou 7
Totale 7.707
Salva come PNG Salva come JPEG
Nome #
Monofocal hepatocellular carcinoma: How much does size matter? 304
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 299
Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise 288
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 267
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 251
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 248
The changing scenario of hepatocellular carcinoma in Italy: an update 229
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 225
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 223
Alcohol and viral hepatitis: a mini-review. 219
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 213
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 212
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 212
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 211
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 211
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 208
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 208
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 206
Vitamins in the treatment of chronic viral hepatitis. 205
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 203
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 202
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 200
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 198
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 194
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 193
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 190
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 190
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 189
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 187
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 186
Chronic hepatitis B: Are we close to a cure? 185
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 184
Treating hepatitis C in the elderly: the future is near? 182
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 181
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung 180
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 177
Liver Stiffness improvement in subjects with advanced chronic hepatitis C treated with direct antiviral agents. 171
Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis 170
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 168
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 165
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 161
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 159
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 156
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 155
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 154
Bile salt export pump deficiency disease: Two novel, late onset, ABCB11 mutations identified by next generation sequencing 154
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 149
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 144
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 142
Liver AL amyloidosis as a possible cause of high liver stiffness values. 136
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals 132
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 130
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 128
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 128
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 126
IMPULSIONAL, POINT AND BIDIMENSIONAL SHEAR WAVE ELASTOMETRY FOR PORTAL HYPERTENSION: SAME STIFFNESS THRESHOLDS? 125
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 125
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 124
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 123
Liver AL amyloidosis as a possible cause of high liver stiffness values. 121
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection. 114
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver. 113
null 107
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 96
null 96
null 92
Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs 52
Totale 11.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.170 0 0 67 82 102 56 19 79 35 128 398 204
2022/20231.458 133 213 70 229 96 127 51 75 242 33 113 76
2023/2024363 29 58 24 31 38 85 11 33 21 18 7 8
2024/20251.383 62 219 113 127 209 71 99 42 18 115 42 266
2025/20263.805 301 165 377 210 388 177 560 185 860 272 141 169
2026/2027301 79 116 106 0 0 0 0 0 0 0 0 0
Totale 11.776